Cargando…
Measurement of Typhi Vi antibodies can be used to assess adaptive immunity in patients with immunodeficiency
Vaccine‐specific antibody responses are essential in the diagnosis of antibody deficiencies. Responses to Pneumovax II are used to assess the response to polysaccharide antigens, but interpretation may be complicated. Typhim Vi(®), a polysaccharide vaccine for Salmonella typhoid fever, may be an add...
Autores principales: | Evans, C., Bateman, E., Steven, R., Ponsford, M., Cullinane, A., Shenton, C., Duthie, G., Conlon, C., Jolles, S., Huissoon, A. P., Longhurst, H. J., Rahman, T., Scott, C., Wallis, G., Harding, S., Parker, A. R., Ferry, B. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980364/ https://www.ncbi.nlm.nih.gov/pubmed/29377063 http://dx.doi.org/10.1111/cei.13105 |
Ejemplares similares
-
The response to Typhi Vi vaccination is compromised in individuals with primary immunodeficiency
por: Kumarage, Jeevani, et al.
Publicado: (2017) -
British Society for Immunology/United Kingdom Primary Immunodeficiency Network consensus statement on managing non‐infectious complications of common variable immunodeficiency disorders
por: Bethune, C., et al.
Publicado: (2019) -
COVID-19 Vaccine Uptake and Efficacy in a National Immunodeficiency Cohort
por: Ponsford, Mark J., et al.
Publicado: (2022) -
British Society for Immunology and United Kingdom Primary Immunodeficiency Network (UKPIN) consensus guideline for the management of immunoglobulin replacement therapy
por: Grigoriadou, S, et al.
Publicado: (2022) -
Immunodeficient patient experience of emergency switch from intravenous to rapid push subcutaneous immunoglobulin replacement therapy during coronavirus disease 2019 shielding
por: Morgan, Clare, et al.
Publicado: (2022)